Monthly Archives: April 2019

BriaCell Announces Publication at American Society of Clinical Oncology (ASCO) Meeting and Presentation at Precision Breast Cancer Summit in Boston

BERKELEY, Calif., and VANCOUVER, British Columbia, April 23, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell’s Lead Candidate Combined With KEYTRUDA®: Strong Evidence of Rapid Additive or Synergistic Anti-Tumor Activity

• As presented at the American Association for Cancer Research (AACR) annual meeting: early efficacy ...

BriaCell Announces Clinical Trial Collaboration Agreement with Incyte

· BriaCell Therapeutics and Incyte have formed a non-exclusive clinical trial collaboration to evaluate the ...

BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million

BERKELEY, Calif., and VANCOUVER, British Columbia, April 1, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...